Rare diseases
Investigational molecules
Locations
Study of XXB750 and Drug Combination for Patients with Heart Failure
GermanyStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GermanyLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
GermanyStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
GermanyStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
GermanyStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
GermanyStudy on the Effects of Riociguat in Patients with Pulmonary Hypertension Due to Left Heart Failure
GermanyStudy on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer
GermanyStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
GermanyStudy on the Effects of Selpercatinib in Patients Aged 12 and Older with Advanced Solid Tumors with RET Gene Alteration
GermanyStudy Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma
GermanyStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
